No record found
* Returns not adjusted for payouts
Company Profile
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Rizwan Ahmad | CEO |
Nadeem Amjad | Chairperson |
Ghulam Dastgeer | Company Secretary |
F.D Registrar Services (Pvt.) Ltd.
Aslam Malik & Co. Chartered Accountants
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 31, 2024 | Transmission of Quarterly Report for the Period Ended | View PDF |
Oct 30, 2024 | Transmission of Quarterly Report for the Period Ended REVOKED | View PDF |
Oct 30, 2024 | Financial Results for the Quarter Ended | View PDF |
Oct 9, 2024 | Transmission of Annual Report for the Year Ended | View PDF |
Oct 2, 2024 | Financial Results for the year ended | View PDF |
Apr 30, 2024 | Transmission of Quarterly Report for the period ended | View PDF |
Apr 26, 2024 | Financial Results for the quarter ended | View PDF |
Mar 4, 2024 | Transmission of Quarterly Report for Period Ended | View PDF |
Feb 29, 2024 | Financial Results for the Quarter Ended 2023-12-31 | View PDF |
Oct 31, 2023 | Transmission of Quarterly Report for the Period Ended September 30, 2023 | View PDF |
Date | Title | Document |
---|---|---|
Oct 30, 2024 | Board Meeting in Progress | View |
Oct 23, 2024 | Board Meeting | View |
Oct 7, 2024 | Notice of Annual General Meeting | View PDF |
Oct 1, 2024 | Board Meeting in Progress | View |
Sep 23, 2024 | Board Meeting | View |
Apr 25, 2024 | Board Meeting in Progress | View |
Apr 18, 2024 | Board Meeting | View |
Feb 21, 2024 | Board Meeting | View |
Oct 20, 2023 | Board Meeting | View |
Oct 6, 2023 | Notice of Annual General Meeting | View PDF |
Date | Title | Document |
---|---|---|
Dec 16, 2024 | Material Information | View PDF |
Dec 10, 2024 | Material Information | View PDF |
Dec 3, 2024 | Material Information | View PDF |
Nov 25, 2024 | Miscellaneous Information | View PDF |
Nov 22, 2024 | Miscellaneous Information REVOKED | View PDF |
Nov 8, 2024 | Dispatch of Final Dividend Warrants | View |
Nov 1, 2024 | Annual Free Float Certificate Duly Verified by Auditor | View PDF |
Oct 11, 2024 | Material Information | View PDF |
Sep 20, 2024 | Material Information | View PDF |
Jul 5, 2024 | Company Secretary | View |
Financials
All numbers in thousands (000's) except EPS
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Sales | 12,409,239 | 12,396,983 | 9,779,880 | 5,795,404 |
Profit after Taxation | 833,464 | 657,984 | 635,884 | 351,768 |
EPS | 3.65 | 2.88 | 2.88 | 3.64 |
Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | |
---|---|---|---|---|
Sales | 3,224,645 | 3,558,874 | 3,275,165 | 2,701,228 |
Profit after Taxation | 201,497 | 211,345 | 375,601 | 94,452 |
EPS | 0.88 | 0.93 | 1.64 | 0.41 |
Ratios
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Gross Profit Margin (%) | 12.78 | 12.16 | 13.83 | 13.47 |
Net Profit Margin (%) | 6.72 | 5.31 | 6.50 | 6.07 |
EPS Growth (%) | 26.74 | (20.88) | (88.58) | |
PEG | 0.29 | (0.54) | (0.11) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
October 2, 2024 2:52 PM | 30/06/2024(YR) | 32.50%(F) (D) | 21/10/2024 - 28/10/2024 |
September 28, 2023 4:07 PM | 30/06/2023(YR) | 25%(F) (D) | 20/10/2023 - 27/10/2023 |
September 30, 2021 9:32 PM | 30/06/2021(YR) | 15% (D) - 10% (B) | 21/10/2021 - 28/10/2021 |